Prosecution Insights
Last updated: April 19, 2026

Mind Medicine Inc.

8 pending office actions

Portfolio Summary

8
Total Pending OAs
3
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19276575 LYOPHILIZED ORALLY DISINTEGRATING TABLET FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS KAMM, JUDITH MARIE 1611 Non-Final OA Jul 22, 2025
18421264 R-MDMA FOR TREATMENT OF PAIN ANDERSON, REBECCA L 1626 Non-Final OA Jan 24, 2024
18543789 SYNTHESIS ROUTES TO ACCESS MDMA PRODRUGS BY USING CONTROLLED AND NON-CONTROLLED INTERMEDIATES CHANDRAKUMAR, NIZAL S 1625 Final Rejection Dec 18, 2023
18344584 METHODS OF MANUFACTURE OF R-MDMA DEKARSKE, MADELINE MCGUIRE 1622 Final Rejection Jun 29, 2023
18331682 MDMA ENANTIOMERS ANDERSON, JAMES D 1629 Non-Final OA Jun 08, 2023
18325655 R-MDMA CRYSTAL FORMS RAO, PADMAJA S 1627 Non-Final OA May 30, 2023
17839374 SYSTEM AND METHOD FOR MONITORING A CONSCIOUSNESS-ALTERING THERAPEUTIC SESSION SIMS, JASON M 3791 Non-Final OA Jun 13, 2022
17518846 MDMA PRODRUGS TO ASSIST PSYCHOTHERAPY SIMMONS, CHRIS E 1622 Final Rejection Nov 04, 2021

Managing Mind Medicine Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month